Nanotechnology in the Era of Covid-19

Abstract

The SARS-CoV-2 virus caused the coronavirus infectious disease (COVID-19), which began in late 2019. The epidemic has now infected around 6 million people and resulted in 350k of deaths, with the number of deaths as of this writing still increasing steadily, affecting most countries across the globe [1].  Initial infections were observed in China’s Wuhan city in December 2019. Those infected showed pneumonia-like symptoms and computed tomography (CT) images of an abnormal lung. Samples from infected patients were tested using a panel of recognized pathogens called multiplex polymerase chain reaction (PCR).